AzTrials
AzTrials

Pregnancy RelatedNCT03851679

Pulmonary Echography and BNP Value Pre- and Post- Elective Cesarean Section in Spinal Anesthesia

An observational study of Pregnancy Related, run by University of Udine.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Pregnancy is characterized by many biohumoral changes: circulation, respiratory mechanics, oncotic pressure, vascular permeability and many other systems are affected. Vascular permeability is controlled by endothelial glycocalyx. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Pregnancy Related
What is being tested?
B-Type natriuretic peptide (BNP) serum values, Pulmonary echography and urine collection
Type of treatment
Medical device
How many people
80 participants
Where
No sites listed yet
Study dates
17 Dec 2016to Nov 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients' anthropometric data were collected, data related to the anesthetic technique, pharmacological and intraoperative fluid therapy, sensory level reached after subarachnoid anesthesia, sensory level and motor blockade at discharge from the operating room. We also collected BNP serum values and pulmonary ultrasound images at 6 and 24 h after the intervention. Diuresis collection at 6 and 24 h after the intervention was registered as well as water balance.

Who may be able to join

  • woman submit elective Cesarean Section:
  • age > 18 years
  • American Society of Anesthesiologists (ASA) physical status classification system > 2
  • > 37 gestational age
  • arterial pressure >/ = 140/90 mmHg and proteinuria < 300 mmHg during anesthesia pre-examination
  • no known cardiovascular/respiratory disease
  • pre-partum pulmonary echography

Who cannot join

  • age < 18 years
  • pulmonary echographic windows not satisfying
  • blood loss during Cesarean Section more than 1000 mL and/or necessity to administer colloid
  • postpartum hemorrhage within the first 24 hours following childbirth
  • pre-eclamptic sign/symptoms within the first 5 days following childbirth
  • twin pregnancy

About this study

Pregnancy is characterized by many biohumoral changes: circulation, respiratory mechanics, oncotic pressure, vascular permeability and many other systems are affected.

Vascular permeability is controlled by endothelial glycocalyx. Several factors such as sepsis, ischemia / reperfusion, inflammatory mediators, trauma, surgery including the Cesarean Section and fluid overload can increase vascular permeability due to a glycocalyx damage.

Read more

During Cesarean Section under subarachnoid anesthesia, hypotension may occur. It is a common side effect caused by reduced preload due to aortocaval compression by the uterus. Furthermore, subarachnoid anesthesia causes block of the sympathetic preganglionic fibers which is associated with vasodilation. These changes often require the use of vasopressors and fluids.

A fluid overload associated with the physiological and pathological factors discussed earlier might cause an increased risk of pulmonary edema and acute respiratory failure (IRA) in women undergoing cesarean section under arachnoid anesthesia.

IRA occurs in less than 0.2% of total pregnancies but it is one of the most common cause of admission to intensive care unit in pregnant women.

Among the causes that can lead to IRA in the last trimester of pregnancy we find pneumopathies such as asthma, pulmonary embolism due to amniotic fluid and pulmonary edema related to severe preeclampsia.

Diagnosis of pulmonary edema can be clinical or sub-clinical through laboratory tests such as BNP (b-type natriuretic peptide). It might also be necessary to execute instrumental examinations such as chest radiography (contraindicated in pregnancy) or trans-thoracic ultrasound.

Hypothesis: correlation between subarachnoid anesthesia, fluidic therapy and BNP values and ultrasound pattern

Being tested
B-Type natriuretic peptide (BNP) serum values, Pulmonary echography, urine collection
Keywords
pulmonary echography, B-Type natriuretic peptide, Spinal anesthesia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • B-Type natriuretic peptide (BNP) serum valuesDiagnostic test

    evaluation BNP serum values:

    • pre- Cesarean Section (30 minutes before surgery)
    • post- Cesarean Section (6 hour and 24 hour after surgery)
  • Pulmonary echographyDevice

    Pulmonary echography:

    • pre- Cesarean Section (30 minutes before surgery)
    • post- Cesarean Section (6 hour and 24 hour after surgery)
  • urine collectionOther

    6 hour and 24 hour urine collection after Cesarean Section

Study groups in NCT03851679
Study groupRoleWhat they receive
pregnancy womanwoman who are submitted to elective Cesarean Section in spinal anesthesia
Receives: Diagnostic Test: B-Type natriuretic peptide (BNP) serum values; Device: Pulmonary echography; Other: urine collection

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ultrasound pulmonary variations

    The main goal of our study is to evaluate, preoperatively, the incidence of ultrasound pulmonary variations in pregnant women attending elective Cesarean Section

    Measured: pulmonary echography is made 30 minutes before Cesarean Section, 6 and 24 hours after surgery

Secondary outcomes (3)
  1. subclinical pulmonary echography variation

    Evaluating the incidence of subclinical variations in ecographic lung characteristics at 6 and 24 hours after Cesarean Section

    Measured: pulmonary echography is made 30 minutes before Cesarean Section, 6 and 24 hours after surgery

  2. B-type natriuretic peptide serum value variation

    Finding if there is any correlation between preoperative b-type natriuretic peptide and ecographic lung characteristics in pregnants, before and 24 hours after Cesarean Section

    Measured: B-type natriuretic peptide serum level is sampled 30 minutes before Cesarean Section, 6 and 24 hours after surgery 30 minutes before Cesarean Section, 6 and 24 hours after surgery

  3. fluid administration and pulmonary echography variation

    Finding if there is any correlation between intraoperative fluids administered and ecographic lung characteristics

    Measured: pulmonary echography is made 30 minutes before Cesarean Section, 6 and 24 hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Feb 2019
  2. Study start17 Dec 2016
  3. Primary completion8 Aug 2018
  4. Study completionNov 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03851679
Sponsor's protocol ID
BNP and pulmonary echography
Status last verified
Feb 2019
First submitted
20 Feb 2019
Last updated
22 Feb 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Bamfo JE, Kametas NA, Nicolaides KH, Chambers JB. Maternal left ventricular diastolic and systolic long-axis function during normal pregnancy. Eur J Echocardiogr. 2007 Oct;8(5):360-8. doi: 10.1016/j.euje.2006.12.004. Epub 2007 Feb 23.

    PubMed 17321800
  • Campos O, Andrade JL, Bocanegra J, Ambrose JA, Carvalho AC, Harada K, Martinez EE. Physiologic multivalvular regurgitation during pregnancy: a longitudinal Doppler echocardiographic study. Int J Cardiol. 1993 Jul 15;40(3):265-72. doi: 10.1016/0167-5273(93)90010-e.

    PubMed 8225661
  • Lapinsky SE. Acute respiratory failure in pregnancy. Obstet Med. 2015 Sep;8(3):126-32. doi: 10.1177/1753495X15589223. Epub 2015 Jun 10.

    PubMed 27512467
  • Pereira A, Krieger BP. Pulmonary complications of pregnancy. Clin Chest Med. 2004 Jun;25(2):299-310. doi: 10.1016/j.ccm.2004.01.010.

    PubMed 15099890
  • Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M. A rational approach to perioperative fluid management. Anesthesiology. 2008 Oct;109(4):723-40. doi: 10.1097/ALN.0b013e3181863117.

    PubMed 18813052
  • Resnik JL, Hong C, Resnik R, Kazanegra R, Beede J, Bhalla V, Maisel A. Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women. Am J Obstet Gynecol. 2005 Aug;193(2):450-4. doi: 10.1016/j.ajog.2004.12.006.

    PubMed 16098869

Questions about this trial

What is this clinical trial studying?

An observational study of Pregnancy Related, run by University of Udine.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ultrasound pulmonary variations (time frame: pulmonary echography is made 30 minutes before Cesarean Section, 6 and 24 hours after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03851679, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Feb 2019; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in